特布他林联合盐酸氨溴索微量吸入治疗毛细支气管炎的临床分析

The clinical analysis of Terbutaline combined with Ambroxol trace inhalation for bronchiolitis

目的:观察特布他林联合盐酸氨溴索微量吸入治疗毛细支气管炎的临床疗效。方法:2010年8月～2011年8月114例毛细支气管炎患儿随机分为两组,对照组57例采用常规治疗,观察组57例在常规治疗基础上给予特布他林联合盐酸氨溴索微量吸入治疗,观察两组的临床疗效及临床症状的变化。结果:观察组的总有效率为89.5%,明显高于对照组的64.9%(P<0.05);观察组咳嗽、喘鸣音、湿啰音消失时间及住院天数明显短于对照组(P<0.05)。结论:特布他林联合盐酸氨溴索微量吸入治疗毛细支气管炎,能够明显提高临床疗效,改善患儿症状,值得临床推广应用。

Objective：To observe the effect of Terbutaline combined with Ambroxol trace inhalation for bronchiolitis. Methods：From August 2010 to August 2011,114 cases of bronchiolitis children were classified into two groups In the control group 57 cases were treated with normal therapy and in the observation group 57 cases were treated with Terbutaline combined with Ambroxol at the basis of normal therapy.The clinical effect and symptom changes between the two groups were compared. Results：The total effective rate in observation group was 89.5%,which was significantly higher than that in control group with 64.9%（P〈0.05）.The disappear time of coughing,wheezing,crackles and hospital stay in observation group were significantly shorter than those in control group（P〈0.05）. Conclusion：Terbutaline combined with Ambroxol trace inhalation for bronchiolitis can enhance effect,and improve patients symptoms,which can be applied in clinic.